G.D. Searle
E476631
G.D. Searle is a pharmaceutical company best known for developing the artificial sweetener aspartame and for its role in pioneering modern drug research before becoming part of larger industry conglomerates.
All labels observed (1)
| Label | Occurrences |
|---|---|
| G.D. Searle canonical | 1 |
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
pharmaceutical company ⓘ |
| acquiredBy | Monsanto Company NERFINISHED ⓘ |
| associatedWith |
Monsanto acquisition of NutraSweet business
ⓘ
controversies over artificial sweeteners ⓘ |
| businessModel |
licensing of sweetener technology
ⓘ
research, development, and commercialization of drugs ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| developed |
artificial sweeteners
ⓘ
aspartame ⓘ |
| field |
drug research
ⓘ
medical research ⓘ pharmacology ⓘ |
| foundedBy | Gideon Daniel Searle NERFINISHED ⓘ |
| hasBrand | NutraSweet NERFINISHED ⓘ |
| hasDivision | Searle Pharmaceuticals NERFINISHED ⓘ |
| hasProduct |
NutraSweet
NERFINISHED
ⓘ
aspartame ⓘ |
| headquartersLocation |
Chicago metropolitan area
NERFINISHED
ⓘ
Skokie, Illinois NERFINISHED ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| integratedInto | larger pharmaceutical conglomerates ⓘ |
| knownFor |
innovation in pharmaceuticals
ⓘ
pioneering modern drug research ⓘ |
| market |
food and beverage sweetener market
ⓘ
global pharmaceutical market ⓘ |
| namedAfter | Gideon Daniel Searle NERFINISHED ⓘ |
| notableContribution |
commercialization of aspartame as a low-calorie sweetener
ⓘ
development of modern clinical research practices ⓘ |
| notableFor | development of aspartame ⓘ |
| operatesInSector |
healthcare
ⓘ
life sciences ⓘ |
| parentOrganization |
Monsanto Company
NERFINISHED
ⓘ
Pfizer NERFINISHED ⓘ |
| partOf | Monsanto Company NERFINISHED ⓘ |
| productType |
artificial sweeteners
ⓘ
food additives ⓘ prescription drugs ⓘ |
| regulatoryDomain | FDA-regulated products ⓘ |
| researchFocus |
food and beverage additives
ⓘ
therapeutic drugs ⓘ |
| roleInIndustry |
early adopter of modern drug development methodologies
ⓘ
pioneer in artificial sweeteners ⓘ |
| status | defunct as an independent company ⓘ |
| successor | Pfizer NERFINISHED ⓘ |
| typeOfBusiness | research-based pharmaceutical company ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.